无血清培养基生产重组人红细胞生成素的纯化
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Study of Purification of Recombinant Human Erythropoietin Produced with FBS-Free Medium
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    用无血清培养基在生物反应器中培养CHO-EPO C2细胞株,培养上清中重组人红细胞生成素表达水平达10~21 mg/L.培养上清经过三步纯化后纯度可达到98%以上,比活性约为1.5×105 U/mg.纯化第一步使用反相柱层析,可将样品体积浓缩约30倍.取其收集液进行DEAE-离子交换柱层析,最后进行分子筛层析,全过程回收率为40%左右.SDS-PAGE表明,所制备终产品分子质量为35~40 ku,等电聚焦方法测其等电点在3.75~4.15之间,均属文献报道范围;ELISA和蛋白质印迹实验结果证明其具有天然红细胞生成素抗原性;采用溴化氰裂解方法做肽谱电泳,结果与理论推测相符.该纯化路线简单、迅速、高效,重复性好,可用于规模化生产临床使用重组人红细胞生成素.

    Abstract:

    CHO-EPO C2 cells were cultured in the Packed Bed Bioreactor with free-fetal bovine serum medium, and the supertant contained 2 000~3 000 U/ml of recombinant Human EPO(rHuEPO). The SDS-PAGE result of the final products from the reported purification schemes was a single band, which purity was over 98% with measurement of UV scanning. The specific activity was 1.5×105 U/mg protein. Reserch showed that the molecular weight was about 35~40 ku and the pI was about 3.75~4.15.The product possessed the antigenity of native HuEPO. The peptide electrophoresis result was in accord with theory deducation. 15 amino acid sequence of rHuEPO N terminal was as the same as native HuEPO. All these results described above revealed that the final product were high purity rHuEPO and the purification procedure was rapid and efficient, which can be used to produce clinic rHuEPO in large scale.

    参考文献
    相似文献
    引证文献
引用本文

李琳,邓继先,卢建申,周江.无血清培养基生产重组人红细胞生成素的纯化[J].生物化学与生物物理进展,1997,24(2):177-182

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:1996-04-18
  • 最后修改日期:1996-08-12
  • 接受日期:
  • 在线发布日期:
  • 出版日期:
关闭